AlleyCorp Job Board

Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Their primary product, TSND-201 (methylone), is aimed at treating Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD), and other Central Nervous System (CNS) indications. The company differentiates itself by focusing on rapid-acting and durable treatments for patients who have not responded to current psychiatric medications. As a Public Benefit Corporation, they are committed to social responsibility, pledging 10% of founding shares to nonprofits focused on scientific research and access. With a leadership team that has contributed to 13 FDA approvals and significant M&A value, Transcend Therapeutics is positioned to make a substantial impact in the mental health space.

Something looks off?

Open jobs at Transcend Therapeutics

This company does not have jobs relevant to this job board at this time.

To view all their jobs, visit their website.

Privacy policy Cookie policy